Yong Zhu

Federal Grant PI High Impact

Professor

UAMS
Last publication 2025 Last refreshed 2026-05-22

faculty

CPH | Epidemiology

yzhu@uams.edu

41 h-index 135 pubs 5,411 cited

Research Areas

Links

ORCID Lab Website Research Group UAMS TRI Profile

OverviewAI-generated summary

Yong Zhu's research program investigates the molecular underpinnings of cancer development, progression, and survival, with a focus on identifying and translating biomarkers. His laboratory's work includes examining the influence of circadian rhythm disruptions, such as night shift work and genetic variations in circadian genes, on tumorigenesis. Additionally, his group conducts translational research centered on small noncoding RNAs, exploring their roles in disease processes.

Dr. Zhu has received federal funding for his work, including a $411,876 grant from the NIH/National Cancer Institute to explore piRNAs as potential biomarkers for early ovarian cancer detection. His scholarly contributions are reflected in a publication record of 135 papers, with 5,408 citations, and an h-index of 41, designating him as a highly cited researcher. He leads a research group and maintains an active laboratory website, indicating ongoing research activities and mentorship.

Metrics

  • h-index: 41
  • Publications: 135
  • Citations: 5,411

Selected Publications

  • Abstract 6243: Mapping risk: spatial analysis of 2,4-D herbicide emissions and colorectal cancer. (2026)
    DOI OpenAlex
  • Abstract 3590: Genetic and immune signaling divergence underlies the inverse associationbetween asthma and cancer. (2026)
    DOI OpenAlex
  • Mapping risk: Spatial analysis of 2,4-D herbicide emissions and colorectal cancer (2025)
    DOI OpenAlex
  • Abstract 2792: PiRNA as a novel therapeutic in hepatocellular carcinoma: insights from population screening (2025)
    DOI OpenAlex
  • Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors (2025)
    DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 1 $411,876 total

NIH/National Cancer Institute Contact PI May 2024 - Apr 2027

Explore piRNAs as a novel group of biomarkers for ovarian cancer early detection

National Cancer Institute $411,876 R21

Grants & Funding

  • ABI C. OBrien NIH COBRE FY26 Y4 State of Arkansas Principal Investigator
  • Explore piRNAs as a novel group of biomarkers for ovarian cancer early detection NIH/Nat. Cancer Institute Principal Investigator
  • Explore piRNAs as a novel group of biomarkers for ovarian cancer early detection NIH/Nat. Cancer Institute Principal Investigator
  • Zhu 2025-2027 Rural Research Award Program CI Cancer Institute Principal Investigator

Collaboration Network

187 Collaborators 74 Institutions 11 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics

Kevin Chappell University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research Bioinformatics and Genomic Networks Epigenetics and DNA Methylation
Good match 4 shared topics
Vinay Raj University of Arkansas at Pine Bluff
Cancer-related molecular mechanisms research Bioinformatics and Genomic Networks Public Health Research
Good match 4 shared topics
Jim Zhongning Chen University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research MicroRNA in disease regulation Epigenetics and DNA Methylation
Good match 4 shared topics
Michael J. Birrer University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research Bioinformatics and Genomic Networks Cancer Immunotherapy and Biomarkers
Good match 4 shared topics
Ebrahim Jakoet University of Arkansas at Little Rock
Cancer-related molecular mechanisms research Bioinformatics and Genomic Networks Epigenetics and DNA Methylation
Related 3 shared topics
H.K. Wong University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research Bioinformatics and Genomic Networks Epigenetics and DNA Methylation
Related 3 shared topics